findmyKOL

Byron Lee, MD

Enriched profile

Professor of Medicine; Samuel T. and Elizabeth Webb Reeves Endowed Chair in Arrhythmia Research, Division of Cardiology · University of California, San Francisco (UCSF)

ORCIDNPI
Region🇺🇸 Palo Alto, CA · West · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusAtrial Fibrillation+1
Active KOLLatest publication2024Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Byron Lee is Professor of Medicine; Samuel T. and Elizabeth Webb Reeves Endowed Chair in Arrhythmia Research, Division of Cardiology at University of California, San Francisco (UCSF). OpenAlex indexes 139 publications with 4,129 citations (h-index 32); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 2 Sept 2026

Byron K. Lee, MD, is Professor of Medicine at University of California, San Francisco (UCSF). The public record shows 139 publications with 4,129 citations (h-index 32), centered on Atrial Fibrillation, Coronary Artery Disease / ACS. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 14 companies.

  • Most recent indexed publication: 2024 · Circulation
  • Top research focus: Atrial Fibrillation
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Disease / ACS1 trialMyocardial Infarction1 trialTachycardia, Ventricular1 trialDeath1 trialVentricular Fibrillation1 trialTachycardia1 trialVentricular Dysfunction1 trialDeath, Sudden1 trialInfarction1 trialAtrial Fibrillation1 trial

Research focus

OpenAlex concept fingerprint
Atrial FibrillationCoronary Artery Disease / ACS

Drugs & molecules

across trials, industry payments and publications
Entrestogeneric · Sacubitril / valsartanClinical trialsIndustry payments1PublicationsLeqviogeneric · InclisiranClinical trialsIndustry payments1PublicationsRepathageneric · EvolocumabClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trialsIndustry payments59Abbott LaboratoriesClinical trialsIndustry payments55Cook IncorporatedClinical trialsIndustry payments9

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
139publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

4,129citations

Total citations across indexed works.

32h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 2 Sept 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 2 Sept 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    69.4%
    Antiarrhythmic36.1%
    Flecainide Acetate48%Amiodarone Hcl28%Propafenone Hcl Er25%
    Part D<11 patients
    Beta blocker33.3%
    Metoprolol Succinate100%
    Part D20 patients
  • Blood & clotting

    22.8%
    Factor Xa inhibitor22.8%
    Eliquis100%
    Part D14 patients
  • Anti-infectives

    7.8%
    First-generation cephalosporins7.8%
    Cephalexin100%
    Part D14 patients
Where care is delivered (Part B)94.9% facility · 5.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 2 Sept 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 2 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Other

    profiles.ucsf.edu/byron.lee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu

Mentions by others

where others cite or feature them
  • Other

    ucsfhealthcardiology.ucsf.edu/facstaff/spotlight/lee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfhealthcardiology.ucsf.edu

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 2 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • M.D.

    Harvard Medical School

    1994
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu
  • Board Certified

    Cardiovascular Disease (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com
  • Board Certified

    Clinical Cardiac Electrophysiology (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com

Editorial & leadership roles

journal and society appointments
  • Director

    UCSF Electrophysiology Laboratories and Clinics

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com
  • Co-Medical Director

    UCSF Heart and Vascular Clinic

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Director

    UCSF Electrophysiology Laboratories and Clinics

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com
  • Affiliated physician

    Zuckerberg San Francisco General Hospital and Trauma Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com
  • Co-Principal Investigator

    VEST (Vest Prevention of Early Sudden Death Trial), international multi-center study

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →tctmd.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.